entertainment -WSS

entertainment

author：Wikipedia 2025-09-03 14:37:03 - browse：222

parts of a dna helix fades while a segment stays solid — Adobe

Flagship Pioneering, the venture capital firm behind Moderna, on Tuesday unveiled a new biotech called Quotient Therapeutics that will have offices in Massachusetts and the United Kingdom.

Quotient, which was founded last year and had operated in stealth mode, wants to develop drugs that target illnesses caused by genetic changes that occur as people age. Those conditions include immune diseases, cancers, neurodegenerative illnesses, and cardiometabolic disorders, such as heart attacks, strokes and diabetes.

With an initial of $50 million from the venture firm Flagship Pioneering, Quotient will be located in Cambridge, Mass., and Cambridge, England. Most of the academic co-founders work in the UK city. Quotient is the first Flagship-backed biotech that will be based in both countries.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： After affirmative action ruling, medical educators look to 'holistic review'
Next article： The woman behind the Dana Farber

WSS

Mega Millions jackpot grows to $720 million ahead of Friday's drawing

Family of Gilgo Beach murder suspect releases statement: 'Devastating time'

What is artificial intelligence? Experts weigh in

Reframing the conversation around gain

Teach medical students about patients with intellectual disabilities

Why the advice to take all your antibiotics may be wrong

knowledge

entertainment

Wikipedia

Anesthesiologist group: stop taking Ozempic before surgery

In diabetes hearing, Sanders takes on a new foe: food makers

Cancer drug shortages should be causing more outrage

Patients' immediate access to test results puts radiologists in a bind

Hollywood unions extend contract negotiations for actors

Biden, Billy Joel, Elton John lead tributes for Tony Bennett after singer's death at 96

DIEP, the 'gold standard' of breast reconstruction, is under threat

Prosecutors say FTX founder Sam Bankman

Walensky prepares to leave CDC — and Congress — behind

Despite FDA approval for Lyfgenia, Bluebird faces stiff competition

Wikipedia

SCOTUS to consider access to abortion pill mifepristone

A former Republican legislative candidate has been charged for his role in the US Capitol riot

In diabetes hearing, Sanders takes on a new foe: food makers

Roche to buy Carmot Therapeutics, developer of obesity drugs

FDA needs staff influx to meet gene therapy needs, Marks says

SCOTUS to consider access to abortion pill mifepristone

hotspot

entertainment

focus

knowledge